AMOEBA SAS (ALMIB.PA) Stock Price & Overview

EPA:ALMIBFR0011051598

Current stock price

0.856 EUR
-0.02 (-1.95%)
Last:

The current stock price of ALMIB.PA is 0.856 EUR. Today ALMIB.PA is down by -1.95%. In the past month the price decreased by -3.82%. In the past year, price decreased by -21.74%.

ALMIB.PA Key Statistics

52-Week Range0.78 - 1.4438
Current ALMIB.PA stock price positioned within its 52-week range.
1-Month Range0.78 - 0.91
Current ALMIB.PA stock price positioned within its 1-month range.
Market Cap
66.614M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.14
Dividend Yield
N/A

ALMIB.PA Stock Performance

Today
-1.95%
1 Week
-1.61%
1 Month
-3.82%
3 Months
-5.62%
Longer-term
6 Months -23.84%
1 Year -21.74%
2 Years +87.10%
3 Years +45.33%
5 Years -62.52%
10 Years N/A

ALMIB.PA Stock Chart

AMOEBA SAS / ALMIB Daily stock chart

ALMIB.PA Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to ALMIB.PA. When comparing the yearly performance of all stocks, ALMIB.PA is a bad performer in the overall market: 87.83% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ALMIB.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ALMIB.PA. ALMIB.PA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALMIB.PA Earnings

Next Earnings DateN/A
Last Earnings DateFeb 23, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

ALMIB.PA Forecast & Estimates

11 analysts have analysed ALMIB.PA and the average price target is 1.53 EUR. This implies a price increase of 78.74% is expected in the next year compared to the current price of 0.856.

For the next year, analysts expect an EPS growth of -7.14% and a revenue growth 963.63% for ALMIB.PA


Analysts
Analysts85.45
Price Target1.53 (78.74%)
EPS Next Y-7.14%
Revenue Next Year963.63%

ALMIB.PA Groups

Sector & Classification

Index Membership

ALMIB.PA Financial Highlights

Over the last trailing twelve months ALMIB.PA reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS decreased by -8.28% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-8.30M
Industry RankSector Rank
PM (TTM) N/A
ROA -81.95%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%2.29%
Sales Q2Q%N/A
EPS 1Y (TTM)-8.28%
Revenue 1Y (TTM)N/A

ALMIB.PA Ownership

Ownership
Inst Owners0.36%
Shares77.82M
Float62.56M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About ALMIB.PA

Company Profile

ALMIB logo image Amoéba SA.is a lyonnaise greentech company based on chassieu whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.

Company Info

IPO: 2015-07-10

AMOEBA SAS

38 avenue des Freres Montgolfier

Chassieu AUVERGNE-RHONE-ALPES FR

Employees: 20

ALMIB Company Website

ALMIB Investor Relations

Phone: 33426691600

AMOEBA SAS / ALMIB.PA FAQ

Can you describe the business of AMOEBA SAS?

Amoéba SA.is a lyonnaise greentech company based on chassieu whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.


What is the current price of ALMIB stock?

The current stock price of ALMIB.PA is 0.856 EUR. The price decreased by -1.95% in the last trading session.


Does AMOEBA SAS pay dividends?

ALMIB.PA does not pay a dividend.


What is the ChartMill technical and fundamental rating of ALMIB stock?

ALMIB.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Which stock exchange lists ALMIB stock?

ALMIB.PA stock is listed on the Euronext Paris exchange.


Can you provide the sector and industry classification for AMOEBA SAS?

AMOEBA SAS (ALMIB.PA) operates in the Materials sector and the Chemicals industry.